Potential Roles and Clinical Utility of Prebiotics in Newborns, Infants, and Children: Proceedings from a Global Prebiotic Summit Meeting, New York City, June 27-28, 2008

Philip M. Sherman, Michael Cabana, Glenn R. Gibson, Berthold V. Koletzko, Josef Neu, Gigi Veereman-Wauters, Ekhard E. Ziegler, W. Allan Walker

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Initial bacterial colonization, including colonization with health-positive bacteria, such as bifidobacteria and lactobacilli, is necessary for the normal development of intestinal innate and adaptive immune defenses. The predominance of beneficial bacteria in the gut microflora of breast-fed infants is thought to be, at least in part, supported by the metabolism of the complex mixture of oligosaccharides present in human breast milk, and a more adult-type intestinal microbiota is found in formula-fed infants. Inadequate gut colonization, dysbiosis, may lead to an increased risk of infectious, allergic, and autoimmune disorders later in life. The addition of appropriate amounts of selected prebiotics to infant formulas can enhance the growth of bifidobacteria or lactobacilli in the colonic microbiota and, thereby, might produce beneficial effects. Among the substrates considered as prebiotics are the oligosaccharides inulin, fructo-oligosaccharides, galacto-oligosaccharides, and lactulose. There are some reports that such prebiotics have beneficial effects on various markers of health. For example, primary prevention trials in infants have provided promising data on prevention of infections and atopic dermatitis. Additional well-designed prospective clinical trials and mechanistic studies are needed to advance knowledge further in this promising field.

Original languageEnglish (US)
Pages (from-to)S61-S70
JournalJournal of Pediatrics
Volume155
Issue number5
DOIs
StatePublished - Nov 1 2009
Externally publishedYes

Fingerprint

Prebiotics
Oligosaccharides
Newborn Infant
Infant Formula
Bifidobacterium
Lactobacillus
Human Milk
Dysbiosis
Bacteria
Lactulose
Inulin
Microbiota
Health
Atopic Dermatitis
Primary Prevention
Complex Mixtures
Breast
Clinical Trials
Growth
Infection

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Potential Roles and Clinical Utility of Prebiotics in Newborns, Infants, and Children : Proceedings from a Global Prebiotic Summit Meeting, New York City, June 27-28, 2008. / Sherman, Philip M.; Cabana, Michael; Gibson, Glenn R.; Koletzko, Berthold V.; Neu, Josef; Veereman-Wauters, Gigi; Ziegler, Ekhard E.; Walker, W. Allan.

In: Journal of Pediatrics, Vol. 155, No. 5, 01.11.2009, p. S61-S70.

Research output: Contribution to journalArticle

Sherman, Philip M. ; Cabana, Michael ; Gibson, Glenn R. ; Koletzko, Berthold V. ; Neu, Josef ; Veereman-Wauters, Gigi ; Ziegler, Ekhard E. ; Walker, W. Allan. / Potential Roles and Clinical Utility of Prebiotics in Newborns, Infants, and Children : Proceedings from a Global Prebiotic Summit Meeting, New York City, June 27-28, 2008. In: Journal of Pediatrics. 2009 ; Vol. 155, No. 5. pp. S61-S70.
@article{ab12e6cd314b47c48d689a52c4113a1b,
title = "Potential Roles and Clinical Utility of Prebiotics in Newborns, Infants, and Children: Proceedings from a Global Prebiotic Summit Meeting, New York City, June 27-28, 2008",
abstract = "Initial bacterial colonization, including colonization with health-positive bacteria, such as bifidobacteria and lactobacilli, is necessary for the normal development of intestinal innate and adaptive immune defenses. The predominance of beneficial bacteria in the gut microflora of breast-fed infants is thought to be, at least in part, supported by the metabolism of the complex mixture of oligosaccharides present in human breast milk, and a more adult-type intestinal microbiota is found in formula-fed infants. Inadequate gut colonization, dysbiosis, may lead to an increased risk of infectious, allergic, and autoimmune disorders later in life. The addition of appropriate amounts of selected prebiotics to infant formulas can enhance the growth of bifidobacteria or lactobacilli in the colonic microbiota and, thereby, might produce beneficial effects. Among the substrates considered as prebiotics are the oligosaccharides inulin, fructo-oligosaccharides, galacto-oligosaccharides, and lactulose. There are some reports that such prebiotics have beneficial effects on various markers of health. For example, primary prevention trials in infants have provided promising data on prevention of infections and atopic dermatitis. Additional well-designed prospective clinical trials and mechanistic studies are needed to advance knowledge further in this promising field.",
author = "Sherman, {Philip M.} and Michael Cabana and Gibson, {Glenn R.} and Koletzko, {Berthold V.} and Josef Neu and Gigi Veereman-Wauters and Ziegler, {Ekhard E.} and Walker, {W. Allan}",
year = "2009",
month = "11",
day = "1",
doi = "10.1016/j.jpeds.2009.08.022",
language = "English (US)",
volume = "155",
pages = "S61--S70",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Potential Roles and Clinical Utility of Prebiotics in Newborns, Infants, and Children

T2 - Proceedings from a Global Prebiotic Summit Meeting, New York City, June 27-28, 2008

AU - Sherman, Philip M.

AU - Cabana, Michael

AU - Gibson, Glenn R.

AU - Koletzko, Berthold V.

AU - Neu, Josef

AU - Veereman-Wauters, Gigi

AU - Ziegler, Ekhard E.

AU - Walker, W. Allan

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Initial bacterial colonization, including colonization with health-positive bacteria, such as bifidobacteria and lactobacilli, is necessary for the normal development of intestinal innate and adaptive immune defenses. The predominance of beneficial bacteria in the gut microflora of breast-fed infants is thought to be, at least in part, supported by the metabolism of the complex mixture of oligosaccharides present in human breast milk, and a more adult-type intestinal microbiota is found in formula-fed infants. Inadequate gut colonization, dysbiosis, may lead to an increased risk of infectious, allergic, and autoimmune disorders later in life. The addition of appropriate amounts of selected prebiotics to infant formulas can enhance the growth of bifidobacteria or lactobacilli in the colonic microbiota and, thereby, might produce beneficial effects. Among the substrates considered as prebiotics are the oligosaccharides inulin, fructo-oligosaccharides, galacto-oligosaccharides, and lactulose. There are some reports that such prebiotics have beneficial effects on various markers of health. For example, primary prevention trials in infants have provided promising data on prevention of infections and atopic dermatitis. Additional well-designed prospective clinical trials and mechanistic studies are needed to advance knowledge further in this promising field.

AB - Initial bacterial colonization, including colonization with health-positive bacteria, such as bifidobacteria and lactobacilli, is necessary for the normal development of intestinal innate and adaptive immune defenses. The predominance of beneficial bacteria in the gut microflora of breast-fed infants is thought to be, at least in part, supported by the metabolism of the complex mixture of oligosaccharides present in human breast milk, and a more adult-type intestinal microbiota is found in formula-fed infants. Inadequate gut colonization, dysbiosis, may lead to an increased risk of infectious, allergic, and autoimmune disorders later in life. The addition of appropriate amounts of selected prebiotics to infant formulas can enhance the growth of bifidobacteria or lactobacilli in the colonic microbiota and, thereby, might produce beneficial effects. Among the substrates considered as prebiotics are the oligosaccharides inulin, fructo-oligosaccharides, galacto-oligosaccharides, and lactulose. There are some reports that such prebiotics have beneficial effects on various markers of health. For example, primary prevention trials in infants have provided promising data on prevention of infections and atopic dermatitis. Additional well-designed prospective clinical trials and mechanistic studies are needed to advance knowledge further in this promising field.

UR - http://www.scopus.com/inward/record.url?scp=71749118190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71749118190&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2009.08.022

DO - 10.1016/j.jpeds.2009.08.022

M3 - Article

C2 - 19840609

AN - SCOPUS:71749118190

VL - 155

SP - S61-S70

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 5

ER -